Both in Pharmaceuticals
Immuneering vs Abeona Therapeutics
Over the past year IMRX returned −44.1% and ABEO returned −10.9%; their daily moves had a correlation of 0.29.
IMRX −44.1% ABEO −10.9%Growth of $1, one year, split-adjusted
| Metric | IMRX | ABEO |
|---|---|---|
| Price | $3.67 | $4.26 |
| Market cap | $237.7M | $243.6M |
| Today | +5.16% | +0.24% |
| 1 month | −9.2% | −16.6% |
| 6 months | −31.3% | −26.9% |
| Year to date | −44.2% | −19.2% |
| 1 year | −46.6% | −11.4% |
| Revenue growth (YoY) | — | +2745.0% |
| Gross margin | — | 63.3% |
| Net margin | — | −177.4% |
| P/E (TTM) | — | — |
| Price / sales | — | 9.5× |
| Net cash | $145.4M | $131.8M |
| Dividend yield | — | — |
| Volatility (60d) | 53.7% | 52.9% |
| Short % of float | 29.2% | 36.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).